MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16806

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    @Bazsa, you seem like an intelligent person. Help me out here.

    30 September is coming up quickly. Mesoblast managed to keep open the door to the $30m in addiotional capital from Oaktree by renegotiating the terms below.

    In connection with the extension to Mesoblast Limited (ASX:MSB; Nasdaq:MESO) by funds managed by Oaktree Capital Management, L.P. ("Oaktree") of the availability of up to an additional US$30.0 million of its US$90 million five year facility (subject to achieving certain milestones on or before September 30, 2023), which was announced on Friday December 23, 2022, Mesoblast will issue 455,000 warrants over American Depository Shares (ADS) (with each ADS representing five fully paid ordinary shares). The warrants have an exercise price of US$3.70 per ADS and are exercisable within
    seven years of issuance .

    So what will happen to this on the 30th of September? I'm assuming that the secret milestones haven't been met. What will the effect be on the working capital of the company?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.